Regeneron Pharmaceuticals, Inc. United States of America (USA)
Research
Date range: 1 August 2022 - 31 July 2023
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Regeneron Pharmaceuticals, Inc. published between 1 August 2022 - 31 July 2023 which are tracked by the Nature Index.
Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
53 | 16.64 |
Outputs by subject (Share)
Subject | Count | Share |
---|---|---|
Biological sciences | 34 | 10.30 |
Chemistry | 1 | 1.00 |
Health sciences | 29 | 9.45 |
Share output for the past 5 years
2018 | 2019 | 2020 | 2021 | 2022* |
---|---|---|---|---|
8.00 | 5.35 | 13.98 | 12.51 | 18.96 |
Compare Regeneron Pharmaceuticals, Inc. with other institutions
*Note: 2022 data contains Share for article affiliations from newly added health-science journals.
Nature Strategy Reports
Nature Strategy Reports gives you simple insights to support decisions that impact your organisation
The reports created for you by our subject matter experts combine compelling insights with Nature’s trust and authority. Get an in-depth analysis of your and your peers’ research performance, including a breakdown of relative strengths and weaknesses. All of which is crafted using data and tools from across Nature Research Intelligence, covering all major disciplines and all regions of the world.
Collaboration
Date range: 1 August 2022 - 31 July 2023
International vs. domestic collaboration by Share
- 51.30% Domestic (195 institutions)
- 48.70% International (446 institutions)
Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators with Regeneron Pharmaceuticals, Inc. by Share*
-
Regeneron Pharmaceuticals, Inc. and Mount Sinai Health System (MSHS)
(3.64)
-
Regeneron Pharmaceuticals, Inc. and Harvard University
(3.07)
-
Regeneron Pharmaceuticals, Inc. and University of Pennsylvania (Penn)
(2.85)
-
Regeneron Pharmaceuticals, Inc. and Northwestern University (NU)
(2.26)
-
Regeneron Pharmaceuticals, Inc. and Geisinger Health System (GHS)
(1.84)
-
Regeneron Pharmaceuticals, Inc. and Columbia University in the City of New York (CU)
(1.81)
-
Regeneron Pharmaceuticals, Inc. and University of California, Irvine (UCI)
(1.63)
-
Regeneron Pharmaceuticals, Inc. and University of Michigan (U-M)
(1.36)
-
Regeneron Pharmaceuticals, Inc. and The University of Texas Southwestern Medical Center (UT Southwestern Medical Center)
(1.24)
-
Regeneron Pharmaceuticals, Inc. and Vanderbilt University (VU)
(1.18)
Top 10 international collaborators with Regeneron Pharmaceuticals, Inc. by Share*
-
Regeneron Pharmaceuticals, Inc. and Sanofi
(2.76)
-
Regeneron Pharmaceuticals, Inc. and University of Oxford
(2.25)
-
Regeneron Pharmaceuticals, Inc. and National Autonomous University of Mexico (UNAM)
(1.75)
-
Regeneron Pharmaceuticals, Inc. and Tecnológico de Monterrey
(1.61)
-
Regeneron Pharmaceuticals, Inc. and Lund University (LU)
(1.49)
-
Regeneron Pharmaceuticals, Inc. and University of Verona (UNIVR)
(1.32)
-
Regeneron Pharmaceuticals, Inc. and Skåne University Hospital (SUS)
(1.11)
-
Regeneron Pharmaceuticals, Inc. and University of Strasbourg
(1.00)
-
Regeneron Pharmaceuticals, Inc. and University of Copenhagen (UCPH)
(0.93)
-
Regeneron Pharmaceuticals, Inc. and Institute of Health Carlos III (ISCIII)
(0.67)
Nature Careers
Need to hire scientific researchers?
Nature Careers is visited by over 180,000 active jobseekers per month that you can target directly with your role. Application response rates have increased by 28% on average over 2022 averages.

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.